Evidence map›Paper›PMID 29673063›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2018

UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival.

Yanhong Hou, Viet Nhat Hung Le, Gábor Tóth, Sebastian Siebelmann, Jens Horstmann, Tim Gabriel, Felix Bock, Claus Cursiefen

Open access · hybridAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Use of corneal cross-linking beyond keratoconus: a systemic literature review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Management of experimental trabeculectomy filtering blebs via crosslinking of the scleral flap inhibited vascularization.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. [Preconditioning of vascularized high-risk eyes using fine-needle diathermy and cross-linking].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Yanhong HouDepartment of Ophthalmology, University of Cologne, Cologne, Germany.ORCID 0000-0003-2248-8441
Viet Nhat Hung LeDepartment of Ophthalmology, University of Cologne, Cologne, Germany.ORCID 0000-0001-9864-782X
Gábor TóthDepartment of Ophthalmology, Semmelweis University, Budapest, Hungary.ORCID 0000-0002-9176-9442
Sebastian SiebelmannDepartment of Ophthalmology, University of Cologne, Cologne, Germany.ORCID 0000-0001-7555-396X
Jens HorstmannDepartment of Ophthalmology, University of Cologne, Cologne, Germany.ORCID 0000-0001-8826-0760
Tim GabrielDepartment of Ophthalmology, University of Cologne, Cologne, Germany.ORCID 0000-0002-0591-5838
Felix BockDepartment of Ophthalmology, University of Cologne, Cologne, Germany.ORCID 0000-0002-5691-8289
Claus CursiefenDepartment of Ophthalmology, University of Cologne, Cologne, Germany.ORCID 0000-0002-1958-411X
University of Cologne · DESemmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunologic graft rejection is the main complication after corneal transplant into pathologically prevascularized so-called high-risk eyes. The aim of this study was to evaluate whether ultraviolet (UV) light crosslinking can regress pathologic corneal blood and lymphatic vessels and thereby improve subsequent graft survival. Using the murine model of suture-induced corneal neovascularization, we found that corneal crosslinking with UVA light and riboflavin regressed both preexisting blood and lymphatic vessels significantly via induction of apoptosis in vascular endothelial cells. In addition, macrophages and CD45

Indexed as

Graft SurvivalUltraviolet RaysAnimalsBlood VesselsCorneal DiseasesCorneal NeovascularizationCorneal TransplantationCross-Linking ReagentsDisease Models, AnimalFemaleLymphangiogenesisLymphatic VesselsMiceMice, Inbred BALB CMice, Inbred C57BLPhotochemotherapyCross-Linking ReagentsRiboflavinanimal models: murinebasic (laboratory) research/sciencecorneal transplantation/ophthalmologygraft survivalimmunohistochemistryorgan transplantation in generalpathology/histopathologyrejectiontolerance: experimentaltranslational research/science

Identifiers

PMID29673063
PMCPMC6282984
OpenAlexW2800900405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.